NCT03226314

Brief Summary

In its report dated april 2014, World Health Organization confirms antibiotic resistance dissemination in all parts of the world, in hospitals and in community and worries about a possible comeback to a pre-antibiotic era during the 21st century. For the last 15 years, third-generation cephalosporins resistant enterobacteriaceae (3GCREB) prevalence is continuously increasing. Community 3GCREB prevalence has not been studied whereas several observations made in Reunion Island hospital suggest a diffusion in community. In this situation of world-wide and regional extension of bacterial resistance, the investigator offers to study bacterial resistance to antibiotic in Reunion Island community.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

November 21, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

March 7, 2019

Status Verified

March 1, 2019

Enrollment Period

1 year

First QC Date

March 3, 2017

Last Update Submit

March 6, 2019

Conditions

Keywords

bacterial multi-resitance

Outcome Measures

Primary Outcomes (1)

  • Digestive prevalence rate of 3GCREB

    estimate of digestive prevalence rate of 3GCREB in participating patients and extrapolation to Reunion Island community population.

    through study completion, an average of 1 day

Study Arms (1)

stool sampled community patients

community patients entering emergency ward or intensive care unit in Reunion Island university hospital and having the stools sampled for bacterial analysis.

Procedure: stool sample

Interventions

stool samplePROCEDURE

study will be proposed to all patients entering emergency ward or intensive care unit in Reunion Island university hospital. Upon consent, a stool sample will be taken (either directly on emitted stools or by rectal sampling) and analysed for enterobacteriaceae.

stool sampled community patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

community patients admitted in emergency ward or in intensive care unit for any condition.

You may qualify if:

  • Patients:
  • aged over 18 years old
  • admitted in emergency ward or intensive care of the university hospital of Reunion Island
  • who received the patient information notice and who gave their consent
  • who have a stool sample performed in the 48 hours following admission
  • who understand and can read French

You may not qualify if:

  • Patients:
  • transferred from a short-term, middle-term or long-term stay health facility
  • who have a stool sample performed more than 48 hours following admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Reunion Island

Saint-Pierre, Reunion Island, 97410, Reunion

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

stools samples

Study Officials

  • Julien JAUBERT, MD

    CHU La Réunion

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2017

First Posted

July 21, 2017

Study Start

November 21, 2017

Primary Completion

December 1, 2018

Study Completion

June 30, 2019

Last Updated

March 7, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations